Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
After five stopgap continuing resolutions since the fiscal year began October 1, and two brief partial government shutdowns, President Trump on Friday signed into law the Omnibus Appropriations Package which included an 8.8 percent year-over-year budget increase for the NIH.
After five stopgap continuing resolutions since the fiscal year began October 1, and two brief partial government shutdowns, President Trump on Friday signed into law the Omnibus Appropriations Package. The legislation provides $37 billion for the National Institutes of Health (NIH), representing an increase of $3 billion, or 8.8 percent, above fiscal year 2017, including $496 million for initiatives authorized by the 21st Century Cures Act.
Most notable for the gene and cell therapy fields, NIH funding includes $10 million in funding for regenerative medicine research, a significant $8 million increase from 2017 funding. The 2018 NIH appropriations also provide an increase of $134 million above fiscal year 2017 for the Food and Drug Administration.
The final legislation did not include a provision contained in the original House appropriations bill (HR 3358) that would have placed restrictions on federal funding for research using human fetal tissue. ASGCT joined 62 other organizations last summer in signing on to a letter opposing such restrictions.
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico